Updates in the 2024 Korean Thyroid Association Clinical Practice Guidelines for Differentiated Thyroid Cancer: from Diagnosis to Initial Treatment
10.11106/ijt.2024.17.2.259
- Author:
Eun Kyung LEE
1
Author Information
1. Department of Internal Medicine, Center for Thyroid Cancer, National Cancer Center, Goyang, Korea
- Publication Type:REVIEW ARTICLES
- From:International Journal of Thyroidology
2024;17(2):259-265
- CountryRepublic of Korea
- Language:English
-
Abstract:
The 2024 Korean Thyroid Association (KTA) Clinical Practice Guidelines for Differentiated Thyroid Cancer (DTC) introduce updated recommendations based on recent advancements and clinical evidence. These guidelines encompass a broad spectrum of DTC cases, from localized thyroid cancer to advanced, treatment-resistant cases, covering both diagnostic and therapeutic approaches. Given the extensive content, careful organization was essential to effectively communicate these updates to KTA members. This article reviews the key changes in the 2024 guidelines, with a focus on revised diagnostic criteria, risk stratification, and initial treatment protocols for DTC. Updates include improved approaches to risk assessment, refinements in surgical intervention guidelines.Additionally, the new guidelines emphasize personalized management strategies that account for individual patient risk profiles and molecular characteristics. These updates aim to enhance diagnostic accuracy, optimize treatment outcomes, and minimize overtreatment for low-risk patients, aligning Korean practices with global standards.
